Table 1.
Types of Angioedema | |||
---|---|---|---|
Mediated by Mast Cells | Mediated by Bradykinin | Mediated by Leukotrienes | |
Pathogenetic Mechanism | • IgE-mediated response to antigen exposure with the release of vasoactive mediators • Non-IgE-mediated (may be associated with chronic spontaneous urticaria) • Idiopathic (unidentifiable cause) |
Complex interaction of complement, coagulation, and contact system • Hereditary angioedema with C1-INH deficiency or defect • Hereditary angioedema with normal C1-INH • Acquired angioedema with C1-INH deficiency • ACE inhibitor-induced angioedema |
Inhibition of cyclooxygenase-1 determines a shunt of the arachidonic acid metabolism and causes an increase in 5-lipoxygenase activity • Induced by NSAIDs, aspirin |
Response to antihistamine in 12 h | Yes | No | |
Urticaria | Frequent | Absent | |
Age of onset | Anyway | Often in the 1st or 2nd decade (40% within 5 years) | Anyway |
Pruritus | Present | Slight | |
Duration of edema | Usually <48 h | Often >72 h | Variable |
Preferred localizations | Face (eyelids, lips), neck | Face, abdomen, extremities | Periorbital, airways |
Prodromal symptoms | No | Often | |
Trauma as a trigger | No | Yes | |
Development of signs and symptoms | Fast | Slower | Hours |
Familiar history | Never | Often | Not known |
Further investigations | Levels of serum tryptase (useful in the context of anaphylaxis/allergenic trigger) |
Serum C4 Quantitative and qualitative levels of C1-INH (all normal in ACE inhibitor-induced angioedema) |